Serum and Tissue LDH Levels in Patients with Breast/Gynaecological Cancer and Benign Diseases

Publisher： Karger

E-ISSN： 1423-002x|67|3|162-168

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.67, Iss.3, 2008-12, pp. : 162-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen and Progesterone Receptors in Benign Ovarian Tumors of Menopausal Breast Cancer Patients Treated with Tamoxifen

By  

Gynecologic and Obstetric Investigation, Vol. 46, Iss. 2, 1998-08 ,pp. : 116-122

Karger

Access to resources Recommend Favorite

Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 1, 2011-03 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Transforming Growth Factor-Alpha Levels in the Serum and Ascites of Patients withAdv anced Epithelial Ovarian Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 47, Iss. 3, 1999-03 ,pp. : 200-204

Karger

Access to resources Recommend Favorite

Evaluation of Serum ProlactinLevels in Patients with Endometriosisand Infertility

By  

Gynecologic and Obstetric Investigation, Vol. 48, Iss. 1, 1999-07 ,pp. : 48-51

Karger

Access to resources Recommend Favorite

Significance of Serum and Peritoneal Fluid Lactate Dehydrogenase Levels in Ovarian Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 49, Iss. 4, 2000-05 ,pp. : 272-274

Karger

Access to resources Recommend Favorite